Published in Cancer Weekly, July 26th, 2005
"Hodgkin lymphoma (HL) has developed into one of the best curable human cancers, and overall about 80% of patients experience long-term disease free survival. Therefore, current treatment strategies aim at further improving treatment outcome, thereby trying to minimize therapy-induced complications, such as infertility, cardiopulmonary toxicity, and secondary malignancies," scientists writing in the European Journal of Haematology reported.
"Ongoing trials investigate a reduction of chemotherapy in terms of dose or cycles given, and the application of lower...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.